Hix Christopher M — SEC insider filings

SEC reporting owner CIK 1357529. 36 insider filings on record with FilingPulse; latest filed 2026-08-28.

Transaction summary — filings shown

Covers all 36 filings on record, filed 2020-12-15 to 2026-08-28. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Enovis CORP (ENOV)EVP, Chief Financial Officer12—15 legs · 157,411 sh · $7,012,80012
ESAB Corp (ESAB)Director20—13 legs · 31,561 sh · $2,470,03732
BRADY CORP (BRC)Director2——2
MIDDLEBY Corp (MIDD)Director2——2

Insider filings — Hix Christopher M

FiledFormIssuerReported transactionsSource
2026-08-284MIDDLEBY Corp (MIDD)Conversion (C): 349EDGAR
2026-03-064MIDDLEBY Corp (MIDD)Grant/award (A): 1,161EDGAR
2025-10-064BRADY CORP (BRC)Grant/award (A): 1,728 @ $78.16EDGAR
2024-10-044BRADY CORP (BRC)Grant/award (A): 1,809 @ $74.63EDGAR
2024-04-014ESAB Corp (ESAB)Grant/award (A): 204 (derivative) @ $0EDGAR
2024-03-054ESAB Corp (ESAB)Sale (S): 7,464 @ $98.91 · Sale (S): 730 @ $98.85 · Sale (S): 878 @ $99.66 · Sale (S): 520 @ $99.08 · Sale (S): 317 @ $99.82 · Sale (S): 2,327 @ $98.83 · +1 moreEDGAR
2024-03-014ESAB Corp (ESAB)Option exercise (M): 10,040 · Option exercise (M): 10,040 (derivative) @ $0EDGAR
2024-02-264ESAB Corp (ESAB)Option exercise (M): 1,673 · Option exercise (M): 1,673 (derivative) @ $0EDGAR
2024-02-214ESAB Corp (ESAB)Option exercise (M): 3,216 · Option exercise (M): 3,216 (derivative) @ $0EDGAR
2024-01-034ESAB Corp (ESAB)Grant/award (A): 260 (derivative) @ $0EDGAR
2023-10-024ESAB Corp (ESAB)Grant/award (A): 321 (derivative) @ $0EDGAR
2023-07-054ESAB Corp (ESAB)Grant/award (A): 339 (derivative) @ $0EDGAR
2023-06-134ESAB Corp (ESAB)Sale (S): 7,500 @ $64.50EDGAR
2023-05-154ESAB Corp (ESAB)Grant/award (A): 1,236 (derivative) @ $0 · Grant/award (A): 3,853 (derivative) @ $0EDGAR
2023-04-034ESAB Corp (ESAB)Grant/award (A): 381 (derivative) @ $0EDGAR
2023-02-284ESAB Corp (ESAB)Option exercise (M): 1,815 · Option exercise (M): 7,625 · Sale (S): 908 @ $57.65 · Sale (S): 3,813 @ $57.65 · Option exercise (M): 1,815 (derivative) @ $0 · Option exercise (M): 7,625 (derivative) @ $0EDGAR
2023-02-244ESAB Corp (ESAB)Option exercise (M): 1,673 · Sale (S): 837 @ $57.62 · Option exercise (M): 1,673 (derivative) @ $0EDGAR
2023-02-224ESAB Corp (ESAB)Option exercise (M): 3,217 · Sale (S): 1,609 @ $57.82 · Option exercise (M): 3,217 (derivative) @ $0EDGAR
2023-01-034ESAB Corp (ESAB)Grant/award (A): 473 (derivative) @ $0EDGAR
2022-12-154ESAB Corp (ESAB)Option exercise (M): 3,930 · Sale (S): 1,965 @ $47.55 · Option exercise (M): 3,930 (derivative) @ $0EDGAR
2022-12-154Enovis CORP (ENOV)Sale (S): 1,367 @ $55.28EDGAR
2022-10-054ESAB Corp (ESAB)Grant/award (A): 674 (derivative) @ $0EDGAR
2022-07-054ESAB Corp (ESAB)Grant/award (A): 514 (derivative) @ $0EDGAR
2022-05-164ESAB Corp (ESAB)Grant/award (A): 1,621 (derivative) @ $0 · Grant/award (A): 4,748 (derivative) @ $0EDGAR
2022-04-074Enovis CORP (ENOV)Other (J): 2,881 @ $0 · Other (J): 1,330 @ $0 · Other (J): 2,453 @ $0 · Other (J): 7,073 @ $0EDGAR
2022-04-074ESAB Corp (ESAB)Grant/award (A): 3,930 (derivative) @ $0 · Grant/award (A): 1,815 (derivative) @ $0 · Grant/award (A): 3,346 (derivative) @ $0 · Grant/award (A): 9,649 (derivative) @ $0EDGAR
2022-03-034Colfax CORP (CFX)Sale (S): 390 @ $39.51 · Sale (S): 1,410 @ $39.52EDGAR
2022-03-014Colfax CORP (CFX)Sale (S): 2,079 @ $42.18 · Grant/award (A): 67,915 @ $0 · Sale (S): 19,330 @ $40.11 · Sale (S): 11,777 @ $41.18 · Sale (S): 100 @ $41.72EDGAR
2022-02-254Colfax CORP (CFX)Sale (S): 1,917 @ $41.83EDGAR
2022-02-224Colfax CORP (CFX)Grant/award (A): 24,050 @ $0EDGAR
2021-12-154Colfax CORP (CFX)Sale (S): 4,345 @ $44.33EDGAR
2021-06-154Colfax CORP (CFX)Option exercise (M): 90,000 @ $26.56 · Sale (S): 89,900 @ $45.89 · Sale (S): 100 @ $46.64 · Option exercise (M): 90,000 (derivative) @ $0EDGAR
2021-03-114Colfax CORP (CFX)Grant/award (A): 11,567 @ $0 · Grant/award (A): 29,484 @ $0 · Sale (S): 13,076 @ $46.74 · Sale (S): 5,130 @ $46.74EDGAR
2021-02-264Colfax CORP (CFX)Sale (S): 2,007 @ $46.01EDGAR
2021-02-244Colfax CORP (CFX)Grant/award (A): 12,513 @ $0 · Grant/award (A): 30,807 (derivative) @ $0EDGAR
2020-12-154Colfax CORP (CFX)Sale (S): 4,483 @ $37.41EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-12-09 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1357529 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs